APA

Cuellar S., Vozniak M., Rhodes J., Forcello N. & Olszta D. (20181001). BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Chicago

Cuellar Sandra, Vozniak Michael, Rhodes Jill, Forcello Nicholas and Olszta Daniel. 20181001. BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Harvard

Cuellar S., Vozniak M., Rhodes J., Forcello N. and Olszta D. (20181001). BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

MLA

Cuellar Sandra, Vozniak Michael, Rhodes Jill, Forcello Nicholas and Olszta Daniel. BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. : Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 20181001.